Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy

Jasim Uddin, Armandoe Gonzalez, Robert H Gilman, Lynette H. Thomas, Silvia Rodriguez, Carlton A W Evans, Daniel G. Remick, Hector H. Garcia, Jon S. Friedland

Research output: Contribution to journalArticle

Abstract

Neurocysticercosis (NCC) due to infection with Taenia solium is a major cause of epilepsy worldwide. Larval degeneration, which may follow antiparasitic treatment, results in clinical symptoms due to inflammatory cell influx. Mechanisms regulating this are not well understood, but chemokines have a key role. Stimulation of human monocytes by cyst Ags from NCC-infected pigs showed that scolex and membrane Ags drive CXCL8 and CCL2 secretion. Antiparasitic treatment of pigs increased CXCL8 in response to brain, but not muscle, cyst Ags. Cyst-fluid Ags did not elicit monocyte chemokine secretion, inhibited LPS-induced CXCL8 by up to 89%, but did not alter CCL2 secretion. This effect was inhibited by anti-IL-10 Abs. Plasma CXCL8, TNF-α, IL-10, eotaxin, IL-1, IL-1ra, soluble IL-1R-II, and soluble TNFR-I and-II levels were evaluated in 167 NCC patients. Patients had lower plasma CXCL8 and TNF-α concentrations than control subjects. In summary, larval Ags from brain and muscle cysts differentially regulate chemokine secretion. Cyst-fluid inhibits CXCL8, and this is blocked by anti-IL-10 Abs. CXCL8 concentrations are decreased in patient plasma. Following anti-parasitic therapy, scolex and membrane Ags are exposed, and cyst fluid is decreased, leading to inflammatory cell influx. Taken together, the cellular, porcine, and human data may explain, in part, why NCC is usually asymptomatic but may cause proinflammatory symptoms, particularly following treatment.

Original languageEnglish (US)
Pages (from-to)4478-4484
Number of pages7
JournalJournal of Immunology
Volume185
Issue number7
DOIs
StatePublished - Oct 1 2010

Fingerprint

Neurocysticercosis
Antiparasitic Agents
Cyst Fluid
Monocytes
Chemokines
Interleukin-10
Cysts
Swine
Chemokine CCL11
Tonic-Clonic Epilepsy
Taenia solium
Receptors, Tumor Necrosis Factor, Type I
Interleukin 1 Receptor Antagonist Protein
Muscles
Membranes
Brain
Therapeutics
Interleukin-1
Infection

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. / Uddin, Jasim; Gonzalez, Armandoe; Gilman, Robert H; Thomas, Lynette H.; Rodriguez, Silvia; Evans, Carlton A W; Remick, Daniel G.; Garcia, Hector H.; Friedland, Jon S.

In: Journal of Immunology, Vol. 185, No. 7, 01.10.2010, p. 4478-4484.

Research output: Contribution to journalArticle

Uddin, J, Gonzalez, A, Gilman, RH, Thomas, LH, Rodriguez, S, Evans, CAW, Remick, DG, Garcia, HH & Friedland, JS 2010, 'Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy', Journal of Immunology, vol. 185, no. 7, pp. 4478-4484. https://doi.org/10.4049/jimmunol.0904158
Uddin, Jasim ; Gonzalez, Armandoe ; Gilman, Robert H ; Thomas, Lynette H. ; Rodriguez, Silvia ; Evans, Carlton A W ; Remick, Daniel G. ; Garcia, Hector H. ; Friedland, Jon S. / Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. In: Journal of Immunology. 2010 ; Vol. 185, No. 7. pp. 4478-4484.
@article{a9de98d8c9ea4ff29271dbdcdd64e72a,
title = "Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy",
abstract = "Neurocysticercosis (NCC) due to infection with Taenia solium is a major cause of epilepsy worldwide. Larval degeneration, which may follow antiparasitic treatment, results in clinical symptoms due to inflammatory cell influx. Mechanisms regulating this are not well understood, but chemokines have a key role. Stimulation of human monocytes by cyst Ags from NCC-infected pigs showed that scolex and membrane Ags drive CXCL8 and CCL2 secretion. Antiparasitic treatment of pigs increased CXCL8 in response to brain, but not muscle, cyst Ags. Cyst-fluid Ags did not elicit monocyte chemokine secretion, inhibited LPS-induced CXCL8 by up to 89{\%}, but did not alter CCL2 secretion. This effect was inhibited by anti-IL-10 Abs. Plasma CXCL8, TNF-α, IL-10, eotaxin, IL-1, IL-1ra, soluble IL-1R-II, and soluble TNFR-I and-II levels were evaluated in 167 NCC patients. Patients had lower plasma CXCL8 and TNF-α concentrations than control subjects. In summary, larval Ags from brain and muscle cysts differentially regulate chemokine secretion. Cyst-fluid inhibits CXCL8, and this is blocked by anti-IL-10 Abs. CXCL8 concentrations are decreased in patient plasma. Following anti-parasitic therapy, scolex and membrane Ags are exposed, and cyst fluid is decreased, leading to inflammatory cell influx. Taken together, the cellular, porcine, and human data may explain, in part, why NCC is usually asymptomatic but may cause proinflammatory symptoms, particularly following treatment.",
author = "Jasim Uddin and Armandoe Gonzalez and Gilman, {Robert H} and Thomas, {Lynette H.} and Silvia Rodriguez and Evans, {Carlton A W} and Remick, {Daniel G.} and Garcia, {Hector H.} and Friedland, {Jon S.}",
year = "2010",
month = "10",
day = "1",
doi = "10.4049/jimmunol.0904158",
language = "English (US)",
volume = "185",
pages = "4478--4484",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "7",

}

TY - JOUR

T1 - Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy

AU - Uddin, Jasim

AU - Gonzalez, Armandoe

AU - Gilman, Robert H

AU - Thomas, Lynette H.

AU - Rodriguez, Silvia

AU - Evans, Carlton A W

AU - Remick, Daniel G.

AU - Garcia, Hector H.

AU - Friedland, Jon S.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Neurocysticercosis (NCC) due to infection with Taenia solium is a major cause of epilepsy worldwide. Larval degeneration, which may follow antiparasitic treatment, results in clinical symptoms due to inflammatory cell influx. Mechanisms regulating this are not well understood, but chemokines have a key role. Stimulation of human monocytes by cyst Ags from NCC-infected pigs showed that scolex and membrane Ags drive CXCL8 and CCL2 secretion. Antiparasitic treatment of pigs increased CXCL8 in response to brain, but not muscle, cyst Ags. Cyst-fluid Ags did not elicit monocyte chemokine secretion, inhibited LPS-induced CXCL8 by up to 89%, but did not alter CCL2 secretion. This effect was inhibited by anti-IL-10 Abs. Plasma CXCL8, TNF-α, IL-10, eotaxin, IL-1, IL-1ra, soluble IL-1R-II, and soluble TNFR-I and-II levels were evaluated in 167 NCC patients. Patients had lower plasma CXCL8 and TNF-α concentrations than control subjects. In summary, larval Ags from brain and muscle cysts differentially regulate chemokine secretion. Cyst-fluid inhibits CXCL8, and this is blocked by anti-IL-10 Abs. CXCL8 concentrations are decreased in patient plasma. Following anti-parasitic therapy, scolex and membrane Ags are exposed, and cyst fluid is decreased, leading to inflammatory cell influx. Taken together, the cellular, porcine, and human data may explain, in part, why NCC is usually asymptomatic but may cause proinflammatory symptoms, particularly following treatment.

AB - Neurocysticercosis (NCC) due to infection with Taenia solium is a major cause of epilepsy worldwide. Larval degeneration, which may follow antiparasitic treatment, results in clinical symptoms due to inflammatory cell influx. Mechanisms regulating this are not well understood, but chemokines have a key role. Stimulation of human monocytes by cyst Ags from NCC-infected pigs showed that scolex and membrane Ags drive CXCL8 and CCL2 secretion. Antiparasitic treatment of pigs increased CXCL8 in response to brain, but not muscle, cyst Ags. Cyst-fluid Ags did not elicit monocyte chemokine secretion, inhibited LPS-induced CXCL8 by up to 89%, but did not alter CCL2 secretion. This effect was inhibited by anti-IL-10 Abs. Plasma CXCL8, TNF-α, IL-10, eotaxin, IL-1, IL-1ra, soluble IL-1R-II, and soluble TNFR-I and-II levels were evaluated in 167 NCC patients. Patients had lower plasma CXCL8 and TNF-α concentrations than control subjects. In summary, larval Ags from brain and muscle cysts differentially regulate chemokine secretion. Cyst-fluid inhibits CXCL8, and this is blocked by anti-IL-10 Abs. CXCL8 concentrations are decreased in patient plasma. Following anti-parasitic therapy, scolex and membrane Ags are exposed, and cyst fluid is decreased, leading to inflammatory cell influx. Taken together, the cellular, porcine, and human data may explain, in part, why NCC is usually asymptomatic but may cause proinflammatory symptoms, particularly following treatment.

UR - http://www.scopus.com/inward/record.url?scp=77958136191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958136191&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.0904158

DO - 10.4049/jimmunol.0904158

M3 - Article

C2 - 20826750

AN - SCOPUS:77958136191

VL - 185

SP - 4478

EP - 4484

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 7

ER -